23 results
6-K
EX-99.1
CALT
Calliditas Therapeutics AB
23 May 24
Interim Report January – March 2024 Q1
4:19pm
and the implementation of CSRD. 14 Environmental matters Climate change mitigation and adaptation Circular economy and waste Social matters Employee health
6-K
EX-99.1
CALT
Calliditas Therapeutics AB
25 Apr 24
Current report (foreign)
4:06pm
change Circular economy and waste Social Health and safety of own workforce Provide access to Calliditas’ products for customers and end-users Health … financial year E1 Climate change E2 Polluon E4 Biodiversity and ecosystems E5 Circular economy & waste G1 Corporate culture G1 Corrupon and bribery
6-K
EX-99.2
CALT
Calliditas Therapeutics AB
21 Feb 24
Calliditas Year-end report, January – December 2023
4:05pm
and waste are relevant issues to Callid-itas, as Calliditas produces relevant amounts of waste in the course of carrying out its preclinical
6-K
EX-99.1
mnqsgoj vy
28 Apr 23
Current report (foreign)
4:05pm
6-K
EX-99.1
zei9cc7arfzj16eotcy
20 Aug 21
Current report (foreign)
5:28pm
6-K
EX-99.2
yg6zh8la2zmtf
18 May 21
Filing of New Drug Application submission to the FDA
9:00am
20-F
ven12xd6w5 ext
27 Apr 21
Annual report (foreign)
5:16pm
6-K
EX-99.1
wmlouyg4n 949ij1
27 Apr 21
Current report (foreign)
12:00am
6-K
EX-99.2
ylcf 7adm
18 Feb 21
Positive Topline Results from Pivotal Phase 3 NefIgArd Trial
8:01am
F-1
k95eyqhhpzccc
26 Jan 21
Registration statement (foreign)
4:33pm
DRS
t7i26 og0vixfkg
29 Dec 20
Draft registration statement
12:00am
6-K
EX-99.2
f8x6v
12 Nov 20
Current report (foreign)
9:23am
6-K
EX-99.3
6otsdoz4ldem9l2lbs9e
13 Aug 20
Calliditas Announces Agreement to Acquire Controlling Interest in Genkyotex SA
7:55am
424B4
4jj iq3au
8 Jun 20
Prospectus supplement with pricing info
9:18am
F-1/A
m6riu1ciw6frn1
1 Jun 20
Registration statement (foreign) (amended)
7:01am
F-1
3yqxzk10 saqmbsl5b
14 May 20
Registration statement (foreign)
8:56am